•  
  •  
  •  
  •  

2026-03-24 18:40:21

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Waaree Energies boosts stake in Transpower Subsidiary to 75.10%
  • NTPC Green Energy Limited inks MoU with Nxtra Data Limited for development of RE Projects
  • TVS Motor Company Ltd declares interim dividend of Rs. 12
  • Cosmic CRF Ltd arm gets order worth Rs. 8.35 crore
  • ITCONS E-Solutions Ltd bags order worth Rs. 1.71 crore

Keywords Selected:  Launch

Research

  • Company Update - Atul Auto - ICICI Direct
  • KPMG in India Report - 5G driving the next growth wave for Digital India
  • Natco Pharma - Natco and Teva launch Revlimid in the US - ICICI Securities

Stock Report

  • Glenmark Pharmaceuticals Launches GLIPIQ® (Semaglutide) In India
  • HCLTech named AWS European Sovereign Cloud launch partner
  • Prithvi Exchange secures in-principle approval from Visa for Forex Card Launch
  • Apis India Limited's Misk launches Masala Dates - Seedless, Superfood-On-The-Go in Bold Indian Flavours
  • Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP, 15 mM P/5 mL, 45 mM P/15 mL and 150 mM P/50 mL (3 mM P/mL) Single-Dose Vials
  • Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry
  • Lupin announces the approval and launch of Brivaracetam Oral Solution in the United States
  • Eris Lifesciences Ltd announces Strategic Partnership with Natco Pharma Ltd for Semaglutide Launch in India
  • Cosmo First to showcase multiple new product launches across businesses at PLASTINDIA 2026
  • Verso Altima India Pvt Ltd launches new products
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial
  • Monarch Networth Capital Ltd launches Its Maiden PMS Scheme
  • Coforge Unveils 'Data Cosmos' - A Next-Gen AI-Enabled, CloudNative Data & Analytics Platform
  • Senores Pharmaceuticals, Inc. announces the approval and launch of Deferiprone Tablets USP, 500 mg & 1000 mg
  • Associated Alcohols & Breweries Ltd launches premium products in the State of Jharkhand
  • Zydus launches biosimilar Denosumab 120 mg SC - protecting bone health in cancer patients
  • Embassy Developments sells 450+ units worth ~₹860 Crore at launch of Embassy Greenshore
  • Vintage Coffee Launches 100% Pure Instant Coffee in India
  • Bansal Wire Industries Ltd launches new product
  • Amrutanjan Healthcare Re-launches Its Iconic Yellow Balm
  • Escorts Kubota Limited Introduces Third-Generation Ride-On Rice Transplanters in India
  • Lenskart launches Meller sunglasses in India
  • Marathon Nextgen Realty Launches ₹600 Crore Residential Development in Panvel
  • Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial

Industry News

  • Liberty General Insurance Launches Surety Insurance Business in India
  • HSBC launches Digital Merchant Services in India
  • Allied Blenders and Distillers Limited brings its Zoya Special Batch Premium Gin to Maharashtra
  • Niva Bupa Health Insurance Introduces 'Aspire', a product for Young India
  • Honeywell Launches World's First 100% Hydrogen-Capable Gas Meter
  • Aviva India Launches Aviva Signature Guaranteed Income Plan

Mutual Funds

  • Mirae Asset Mutual Fund launches two new Target Maturity Index Funds

Latest Post

  • Waaree Energies boosts stake in Transpower Subsidiary to 75.10%
  • NTPC Green Energy Limited inks MoU with Nxtra Data Limited for development of RE Projects
  • TVS Motor Company Ltd declares interim dividend of Rs. 12
  • Cosmic CRF Ltd arm gets order worth Rs. 8.35 crore
  • ITCONS E-Solutions Ltd bags order worth Rs. 1.71 crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025